Zhongyianke Biotech
Zhongyianke Biotech is a biotechnology firm
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BEquity / VC | Jul 2020 | $0 | — | Med-Fine Capital | — |
| SERIES A✓Equity / VC | Jul 2019 | $36M | $144M | Efung Capital | — |
Growth signals
Latest recorded traffic for Zhongyianke Biotech is 100 monthly website visits, down 37.5% over the last three months. Zhongyianke Biotech's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Zhongyianke Biotech in its local ecosystem
The Zhongyianke Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- ECEfung Capital
Med-Fine Capital
Other known investors1 additional known investor
Chinese Academy Of Sciences
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zhongyianke Biotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zhongyianke Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









